Search Results for: IONI
Akcea Therapeutics stock jumped on Monday after it was announced that Ionis Pharmaceuticals would be acquiring all of its outstanding shares.
6 months ago
Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular disease study.
1 year ago
Last Updated: 1 year ago
Medicines Co shares shot up on Monday after it was reported that Novartis will be acquiring the firm. The transaction was unanimously approved by the boards of directors of both companies.
1 year ago
Last Updated: 1 year ago
Medicines shares shot up on Tuesday after it was reported that Novartis might be eyeing this company as its newest acquisition.
1 year ago
Last Updated: 1 year ago
The 55th annual meeting of the American Society of Clinical Oncology (ASCO) is just around the corner. Biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference...
1 year ago
Last Updated: 1 year ago
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
1 year ago
Last Updated: 1 year ago
Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.
2 years ago
Last Updated: 1 year ago
Akcea Therapeutics shares pulled back on Monday after the company announced a big change to its board of directors.
2 years ago
Last Updated: 1 year ago
Akcea and Ionis Pharmaceuticals shares made a solid gain on Monday after the companies announced positive top-line data for a midstage trial in patients with established cardiovascular disease and...
2 years ago
Last Updated: 1 year ago
Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.
2 years ago
Last Updated: 1 year ago
Akcea Therapeutics shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals that they had received a marketing authorization approval from the...
2 years ago
Last Updated: 1 year ago
Ionis Pharmaceuticals shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen.
2 years ago
Last Updated: 1 year ago
Akcea Therapeutics expects to price more than 9 million shares in the range of $12 to $14 apiece in an initial public offering valued up to almost $155 million.
3 years ago
Last Updated: 1 year ago
Ionis Pharmaceuticals saw its shares pullback on Monday morning after results were released from its late-stage trial for the treatment of familial amyloid polyneuropathy.
3 years ago
Last Updated: 1 year ago
Akcea Therapeutics has amended its filing with the SEC for its initial public offering.
3 years ago
Last Updated: 1 year ago
Subscribe to Our Newsletter
Signup for our weekly newsletter to get the latest news, updates & amazing offers delivered directly to your inbox